Insights on recent shifts in U.S. health policy: autism research, drug pricing reforms, HHS operational cuts, abortion access, and legal challenges to insurance preventive care coverage.

Social Security in Houston faces increasing delays due to staffing cuts and higher call volumes, impacting benefit approvals and service access. Learn how these challenges affect Texas beneficiaries and federal service modernization efforts.

HaysMed CEO Edward Herrman joined a key HHS healthcare policy roundtable discussing rural healthcare challenges, Medicare Advantage concerns, regulatory burdens, and AI opportunities. Insights to inform federal support and reform.

U.S. Rep. Richard Neal discusses the potential impact of federal budget cuts to Medicaid and Medicare on Massachusetts long-term care providers and residents.

Explore how Medicare Part D and C plans cover Jardiance for heart failure and type 2 diabetes, including costs, formularies, and pricing reforms under the Inflation Reduction Act.

Medicare beneficiaries face higher costs as Part D plans shift from fixed co-pays to coinsurance for expensive Tier 3 drugs, raising out-of-pocket expenses significantly.

Caremark is accused of overbilling Medicare Part D by $240-$330 million in a whistleblower lawsuit, raising significant regulatory and compliance concerns for PBMs.

Genexe and Immerge settle $6M case resolving false Medicare claims for unnecessary genetic tests involving kickbacks. Settlement addresses healthcare fraud and whistleblower suits under the False Claims Act.

Medicare Advantage faces scrutiny amid efforts to reduce waste in federal healthcare spending, highlighting challenges in cost efficiency and regulatory oversight.

U.S. cancer death rates declined steadily from 2001 to 2022, including during the pandemic, driven by advances in detection and treatment. Regulatory fraud enforcement and new FDA approvals impact healthcare and insurance sectors.